Hypothyroidism induced by quetiapine: A case report [1]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 2, 2006, Pages 208-209

  Liappas, John ^a   Paparrigopoulos, Thomas ^a   Mourikis, Iraklis ^a   Soldatos, Constantin ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HALOPERIDOL; LITHIUM; PAROXETINE; QUETIAPINE; VENLAFAXINE; ZOLPIDEM;

ADULT; CASE REPORT; DRUG MECHANISM; DYSTHYMIA; FEMALE; HUMAN; HYPOTHYROIDISM; LETTER; MAJOR DEPRESSION; PRIORITY JOURNAL; THYROID FUNCTION;

ANTIPSYCHOTIC AGENTS; DEPRESSIVE DISORDER, MAJOR; DIBENZOTHIAZEPINES; DRUG MONITORING; FEMALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; THYROID HORMONES;

EID: 33646709413     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000203227.56494.ff     Document Type: Letter

References (15)

1. Seroquel (quetiapine fumarate) [product monograph]. Rev 07/04. Wilmington, DE: AstraZeneca Pharmaceuticals; 2004.
2. Tariot PN, Salzman C, Yeung PP, et al. Long-term use of quetiapine in elderly patients with psychotic disorders. Clin Ther. 2000;22(9):1068-1084.
3. McManus DQ, Arvanitis LA, Kowalcyk BB. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. J Clin Psychiatry. 1999;60(5):292-298.
4. Shaw JA, Lewis JE, Pascal S, et al. A study of quetiapine: efficacy and tolerability in psychotic adolescents. J Child Adolesc Psychopharmacol. 2001;11(4):415-424.
5. Feret BM, Caley CF. Possible hypothyroidism associated with quetiapine. Ann Pharmacother. 2000;34(4):483-486.
6. Dobbs RL, Brahm NC, Fast G, et al. Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescent. Ann Pharmacother. 2004;38(9):1541-1542.
7. Ramaswamy S, Siddiqui Z, Saharan S, et al. Quetiapine-induced hypothyroidism. J Psychiatry Neurosci. 2005;30(1):57.
8. Kelly DL, Conley RR. Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine. J Clin Psychiatry. 2005;66:80-84.
9. Arvanitis LA, Miller BG. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry. 1997;42:233-246.
10. Mariotti S, Caturegli M, Piccolo P, et al. Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab. 1990;71:661-669.
11. Leroy MC, Villeneuve A, Lajeunesse C. Lithium, thyroid function and antithyroid antibodies. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(4):483-490.
12. Lazarus JH. The effects of lithium therapy on thyroid and thyrotroprn-releasing hormone. Thyroid. 1998;8(10):909-913.
13. Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry. 2000;176:495-496.
14. Carta MG, Hardoy MC, Boi MF, et al. Association between panic disorder, major depressive disorder and celiac disease. A possible role of thyroid autoimmunity. J Psychosom Res. 2002;53:789-793.
15. Carta MG, Loviselli A, Hardoy MC, et al. The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry. August 18, 2004;4:25 [doi:10.1186/1471-244X-4-25].